proarrhythmic

the drug has potent proarrhythmic effects on patients with underlying heart conditions.

proarrhythmic complications can occur even with standard dosing of the medication.

the study identified several proarrhythmic risk factors in cardiac patients.

healthcare providers must monitor for proarrhythmic events during treatment.

some antiarrhythmic medications can exhibit proarrhythmic properties.

the patient experienced a proarrhythmic response to the new drug.

proarrhythmic potential was observed in the clinical trial data.

elderly patients are particularly vulnerable to proarrhythmic effects.

the mechanism of proarrhythmic action involves ion channel disruption.

qt prolongation is a known proarrhythmic mechanism.

proarrhythmic events require immediate medical intervention.

the drug's proarrhythmic profile was carefully evaluated before approval.